2026 guidance

Sinclair projects strong 2026 growth driven by political ad spending and sports programming, expecting $333M in political ads and $700-740M Adjusted EBITDA.

Ferguson beat Q4 expectations with strong commercial growth offsetting residential weakness. Non-residential revenue surged 10% while residential declined 2% amid housing market challenges.

HSBC shares hit 52-week peak after strong Q4 earnings beat. Bank reported 42% revenue growth and exceeded profit expectations, boosting investor confidence.

Astec Industries reported record Q4 sales of $400.6M, with Materials Solutions surging 60%. Full-year adjusted EBITDA rose 25.8% to $140.7M, supported by infrastructure spending.

Martin Marietta swapped cement assets for aggregates operations worth 20 million tons annually across four regions, raising 2026 guidance on expected 12% volume growth.

Forum Energy Technologies beat Q4 earnings estimates and raised 2026 outlook, projecting 6% revenue growth and 16% EBITDA increase. Stock jumped 6.84%.

EPAM stock plunges 16.4% despite beating Q4 earnings due to weak 2026 guidance. Investors worry about AI's impact on consulting demand and growth deceleration.

Southern Company beat revenue targets at $6.98B but missed EPS estimates at $0.55. Stock rose 3.49% as strong operational performance outweighed earnings shortfall.

EPAM shares fell 18.4% despite beating earnings expectations, as investors worry about declining profitability and margin compression despite revenue growth.

B2Gold shares fell 8.92% despite record 2025 revenue of $3.06 billion, as 2026 guidance projects lower production and significantly higher costs.

Vita Coco reports 18% revenue growth to $610M, driven by strong coconut water demand. Company projects 11-15% growth in 2026.

OGE Energy raises 2026 guidance to $2.38-$2.48 EPS, citing infrastructure investment gains and load growth. Company projects 5-7% annual EPS growth through 2028.

Devon Energy released 2025 results and maintained its quarterly dividend, demonstrating confidence in cash generation and strategic positioning in the energy market.

Myriad Genetics reports 2025 results February 23, 2026, while preparing March launch of Precise MRD cancer detection product. Strong clinical data supports expansion.

DraftKings stock fell 13.73% despite beating Q4 earnings, as cautious 2026 guidance projecting just 11% growth spooked investors expecting faster momentum.